Diabetes Professional Care (DPC) is a free-to-attend, CPD-accredited, conference and exhibition for healthcare professionals (HCPs) involved in the prevention, treatment and management of diabetes, and its related conditions.
Mesh for vaginal wall prolapse should only be used in research: NICE
NICE’s updated advice says current evidence on the safety of the vaginal mesh shows there are serious, but well-recognised safety concerns.
The evidence for long-term efficacy is inadequate in quality and quantity. Therefore, the procedure should only be used in the context of research. This does not constitute a ban on the use of the procedure however.
NICE has published eight pieces of interventional procedure guidance (IPG) on mesh. It gives advice on the use of mesh as a treatment for stress urinary incontinence (SUI), or pelvic organ prolapse (POP).
The publication focuses on the use of mesh for vaginal wall prolapse, which is a type of POP. It is the last of eight IPGs to be updated.
Andrew Dillon, NICE chief executive, said: “Our updated advice on surgical procedures using mesh is based on the latest evidence available, which has been considered in the light of the serious concerns expressed by individual patients and patient groups. We emphasise the importance of patient consent and data collection and we are confident that our advice will give patients and health professionals the right information to make treatment decisions.”